Erbitux Offers 'cure' Potential To 3 Out Of 4 Advanced Colon Cancer Patients - But Conditions Apply
Researchers have narrowed down the conditions in metastatic colorectal cancer (mCRC) where treatment with the targeted biologic therapy Erbitux (cetuximab) is most likely to succeed...
[read article]